UNSPSC 51143205: Altinicline

This classification denotes a cholinergic agonist with the molecular formula C12H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RJ9V9V09VM, chemically known as pyridine, 3-ethynyl-5-((2s)-1-methyl-2-pyrrolidinyl)- but generally known as altinicline, which bears US NIH Compound Identifier 3036156. Altinicline most often comes in base and maleate forms. The term ALTINICLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44).

Most nations schedule altinicline under HS 29339990 and SITC 51577. As of Q4 2014, ALTINICLINE remains the US FDA Preferred Term for this commodity. Altinicline bears US NLM identifiers UMLS ID C2698073 and NCI Concept Code C77841. SMILES: CN1CCCC1C2=CN=CC(=C2)C#C.

UNSPSC 51143205 Altinicline is a Commodity code that encompasses pharmaceutical products used in emergency medical response and harm reduction, grounded in state and local procurement activity around naloxone and related drug intervention systems. State and local governments procure these products primarily through county public health departments and community health initiatives, with the buying pattern emphasizing quarterly replenishment cycles and bulk annual quantities. The solicitations reflect health and safety operations within general-purpose governments rather than specialized medical suppliers or pharmacy networks.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2023. The opportunity illustrates the scope of procurement under this code—emergency response pharmaceuticals bundled with complementary harm-reduction systems, with vendors responsible for all shipping and delivery costs, fixed-fee pricing structures, and standard compliance requirements including E-Verify, drug-free workplace certification, and insurance coverage. The contract term was structured for an initial two-year period with a one-year renewal option, and the procurement carried potential FEMA funding implications with associated federal environmental compliance requirements. No set-aside designations for disadvantaged enterprises were specified in the notice.